Auf dieser Seite
ARCT Arcturus Therapeutics Holdings Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$13,03
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$5,5052-Wochen-Tief
$24,1752-Wochen-Hoch
Marktkapitalisierung (MRQ)
$370M
P/E (TTM)
-3.9
EPS (TTM)
$-3.33
Umsatz (TTM)
$29M
Ihre Abzeichen
52W-Spanne
$6–$24
Analystenbewertung
BUY
Kursziel
$23
P/E
-3.9
ROE
-46.3%
Nettogewinnmarge
-317.6%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
ARCT Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$13.03
Marktkapitalisierung (MRQ)
$370M
P/E (TTM)
-3.9
EPS (TTM)
$-3.33
Umsatz (TTM)
$29M
ROE (TTM)
-46.3%
52W-Spanne
$6–$24
ARCT Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 16. November 2017 | 1-for-7 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$82M2018-12-31 → 2025-12-31
EPS$-2.402021-12-31 → 2025-12-31
Freier Cashflow$-75M2019-12-31 → 2025-12-31
Nettogewinnmarge-317.6%2019-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | ARCT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -3.95-Jahres-Durchschnitt ≈1.5 | ≈1.5 | · | · | |
| P/S (TTM) | 12.65-Jahres-Durchschnitt ≈18.3 | ≈18.3 | 6.5 | Fairer Wert | |
| K/B (MRQ) | 2.25-Jahres-Durchschnitt ≈2.3 | ≈2.3 | 2.7 | Unterbewertet | |
| Kurs / FCF (TTM) | -5.15-Jahres-Durchschnitt ≈-7.7 | ≈-7.7 | · | · | |
| Kurs / Cashflow (TTM) | -5.15-Jahres-Durchschnitt ≈-10.0 | ≈-10.0 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 1.75-Jahres-Durchschnitt ≈2.3 | ≈2.3 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | ARCT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -348.3%5-Jahres-Durchschnitt ≈-367.6% | ≈-367.6% | -246.3% | Schwach | |
| EBITDA Margin (EBITDA-Marge) | -93.0%5-Jahres-Durchschnitt ≈-367.6% | ≈-367.6% | -245.4% | Schwach | |
| Pretax Margin (Vorgewinnmarge) | -80.2%5-Jahres-Durchschnitt ≈-358.6% | ≈-358.6% | -245.7% | Schwach | |
| Nettogewinnmarge (TTM) | -317.6%5-Jahres-Durchschnitt ≈-358.9% | ≈-358.9% | -459.6% | Schwach | |
| ROA (TTM) | -35.0%5-Jahres-Durchschnitt ≈-18.7% | ≈-18.7% | -30.6% | Spitzenklasse | |
| ROE (TTM) | -46.3%5-Jahres-Durchschnitt ≈-30.3% | ≈-30.3% | -39.5% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | ARCT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 5.95-Jahres-Durchschnitt ≈4.6 | ≈4.6 | 5.8 | Im Einklang | |
| Quick Ratio | 6.55-Jahres-Durchschnitt ≈4.2 | ≈4.2 | 3.3 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | ARCT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -46.1%5-Jahres-Durchschnitt ≈304.5% | ≈304.5% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -26.4%5-Jahres-Durchschnitt ≈88.0% | ≈88.0% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 53.8% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | ARCT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.35-Jahres-Durchschnitt ≈0.3 | ≈0.3 | 0.2 | Spitzenklasse | |
| Receivables Turnover (Forderungsumschlag) | 17.25-Jahres-Durchschnitt ≈21.4 | ≈21.4 | 7.9 | Spitzenklasse | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$773.9K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
26.1%
Nächster Bericht
Nov 09, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 10, 2026 | $-0.84 | $-1.02 | 17.5% |
| 31. März 2026 | Mai 11, 2026 | $-0.95 | $-1.11 | 14.4% |
| 31. Dezember 2025 | $-1.03 | $-0.73 | -41.6% | |
| 30. September 2025 | $-0.49 | $-0.84 | 41.6% | |
| 30. Juni 2025 | $-0.34 | $-0.91 | 62.6% | |
| 31. März 2025 | $-0.52 | $-1.36 | 61.7% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $82M | $152M | $167M | $206M | $12M | $10M | $21M | $16M | |
| R&D Expense | $112M | $195M | $192M | $148M | $174M | $58M | $34M | $17M | |
| SG&A Expense | $46M | $53M | $53M | $46M | $41M | $23M | $13M | $21M | |
| Operating Expenses | $158M | $248M | $245M | $194M | $215M | $81M | $46M | $38M | |
| Operating Income | $-76M | $-96M | $-78M | $12M | $-203M | $-72M | $-26M | $-22M | |
| Other Non-op | $10M | $15M | $17M | $-420.0K | $-2M | $-361.0K | $-446.0K | $328.0K | |
| Pretax Income | $-66M | $-81M | $-28M | $11M | $-204M | $-72M | $-26M | $-22M | |
| Income Tax | · | $-4.0K | $2M | $1M | · | · | · | · | |
| Net Income | $-66M | $-81M | $-30M | $9M | $-204M | $-72M | $-26M | $-22M | |
| EPS (Basic) | $-2.40 | $-3.00 | $-1.12 | $0.35 | $-7.74 | · | · | · | |
| EPS (Diluted) | $-2.40 | $-3.00 | $-1.12 | $0.35 | $-7.74 | · | · | · | |
| Shares (Basic) | 27,386,000 | 27,000,000 | 26,628,000 | 26,445,000 | 26,317,000 | · | · | · | |
| Shares (Diluted) | 27,386,000 | 27,000,000 | 26,628,000 | 27,093,000 | 26,317,000 | · | · | · | |
| EBITDA | $-76M | $-96M | $-78M | $12M | $-203M | $-72M | $-26M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $231M | $237M | $292M | $392M | $370M | $463M | $71M | $37M | |
| Receivables | $6M | $4M | $32M | $3M | $3M | $2M | $2M | $4M | |
| Prepaid Expense | · | · | · | · | · | · | $720.0K | $546.0K | |
| Other Current Assets | · | · | · | · | · | · | $38.0K | $92.0K | |
| Current Assets | $241M | $306M | $387M | $403M | $379M | $468M | $74M | $42M | |
| PP&E (Net) | $7M | $10M | $12M | $12M | $6M | $3M | $2M | $2M | |
| PP&E (Gross) | $19M | $21M | $21M | $18M | $10M | $6M | $5M | $3M | |
| Accum. Depreciation | $12M | $12M | $9M | $6M | $4M | $3M | $2M | $1M | |
| Total Assets | $271M | $344M | $429M | $450M | $393M | $476M | $82M | $44M | |
| Accounts Payable | $4M | $7M | $5M | $7M | $10M | $11M | $6M | $2M | |
| Accrued Liabilities | $24M | $39M | $32M | $30M | $24M | $19M | $7M | $4M | |
| Current Liabilities | $36M | $65M | $82M | $127M | $100M | $50M | $21M | $13M | |
| Capital Leases | $21M | $25M | $26M | $30M | $5M | $4M | $5M | · | |
| Other Non-current Liabilities | · | · | $497.0K | $3M | · | · | · | · | |
| Total Liabilities | $57M | $103M | $151M | $180M | $165M | $80M | $56M | $31M | |
| Long-term Debt | · | · | · | · | $15M | $15M | $15M | · | |
| Total Debt | · | · | · | $61M | $63M | $15M | $15M | · | |
| Common Stock | $28.0K | $27.0K | $27.0K | $27.0K | $26.0K | $26.0K | $15.0K | $214.0K | |
| Paid-in Capital | $729M | $690M | $646M | $608M | $576M | $540M | $97M | $58M | |
| Retained Earnings | $-515M | $-449M | $-368M | $-338M | $-347M | $-144M | $-72M | $-45M | |
| Stockholders' Equity | $214M | $241M | $279M | $270M | $228M | $397M | $26M | $14M | |
| Liabilities + Equity | $271M | $344M | $429M | $450M | $393M | $476M | $82M | $44M | |
| Shares Outstanding | 28,414,000 | 27,000,000 | 26,828,000 | 26,555,000 | 26,372,000 | 26,192,000 | 15,138,000 | 10,719,000 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $4M | $3M | $2M | $1M | $882.0K | $684.0K | $582.0K | |
| Stock-based Comp | $25M | $38M | $35M | $31M | $29M | $7M | $2M | $1M | |
| Operating Cash Flow | $-74M | $-60M | $-18M | $32M | $-135M | $-43M | $-6M | $-21M | |
| CapEx | $230.0K | $648.0K | $3M | $8M | $3M | $2M | $818.0K | $1M | |
| Investing Cash Flow | $-230.0K | $-648.0K | $-3M | $-8M | $-3M | $-2M | $-818.0K | $22M | |
| Debt Issued | · | · | · | · | $47M | · | $5M | $10M | |
| Net Debt Issued | · | · | · | · | $47M | · | $5M | · | |
| Stock Issued | $12M | · | · | · | · | $424M | $21M | · | |
| Net Stock Activity | $12M | · | · | · | · | $424M | $21M | · | |
| Financing Cash Flow | $13M | $5M | $-24M | $-3M | $48M | $436M | $42M | $10M | |
| Net Change in Cash | $-61M | $-55M | $-45M | $21M | $-90M | $392M | $35M | $12M | |
| Taxes Paid | · | $1M | · | · | · | · | · | · | |
| Free Cash Flow | $-75M | $-60M | $-21M | $24M | $-138M | $-45M | $-7M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -93.0% | -62.8% | -46.9% | 5.9% | -1641.3% | -749.8% | -122.7% | · | |
| Net Margin | -80.2% | -53.1% | -17.8% | 4.5% | -1648.0% | -756.4% | -125.0% | · | |
| Pretax Margin | -80.2% | -53.1% | -16.7% | 5.2% | -1648.0% | -756.4% | -125.0% | · | |
| EBITDA Margin | -93.0% | -62.8% | -46.9% | 5.9% | -1641.3% | -749.8% | -122.7% | · | |
| ROA | -21.4% | -20.9% | -6.8% | 2.2% | -46.9% | -25.8% | -41.1% | · | |
| ROE | -29.6% | -32.2% | -10.6% | 4.5% | -83.6% | -21.9% | -84.3% | · | |
| ROIC | · | -39.7% | -29.9% | 3.2% | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.6 | 4.7 | 4.7 | 3.2 | 3.8 | 9.4 | 3.5 | · | |
| Quick Ratio | 6.5 | 3.7 | 4.0 | 3.1 | 3.8 | 9.4 | 3.4 | · | |
| Debt / Equity | · | · | · | 0.2 | 0.3 | 0.0 | 0.6 | · | |
| LT Debt / Equity | · | · | · | · | 0.2 | 0.0 | 0.6 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.4 | 0.4 | 0.5 | 0.0 | 0.0 | 0.3 | · | |
| Receivables Turnover | 17.2 | 8.5 | 9.6 | 67.2 | 4.5 | 4.4 | 6.2 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.53 | $8.93 | $10.38 | $10.18 | $8.65 | $15.14 | $1.70 | · | |
| Revenue / Share | $3.00 | $5.64 | $6.26 | $7.60 | · | · | · | · | |
| Cash Flow / Share | $-2.71 | $-2.21 | $-0.68 | $1.18 | · | · | · | · | |
| Cash / Share | $8.13 | $8.78 | $10.88 | $14.76 | $14.05 | $17.67 | $4.71 | · | |
| EPS (TTM) | $-2.40 | $-3.00 | $-1.12 | $0.35 | $-7.74 | · | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -46.1% | -8.7% | -19.0% | 1566.8% | 29.6% | · | · | · | |
| Revenue CAGR 3Y | -26.4% | 131.0% | 159.6% | · | · | · | · | · | |
| Revenue CAGR 5Y | 53.8% | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $82M | $152M | $167M | $206M | $12M | $10M | $21M | · | |
| Net Income TTM | $-66M | $-81M | $-30M | $9M | $-204M | $-72M | $-26M | · | |
| Market Cap | $174M | $458M | $846M | $450M | $976M | $1.14B | $165M | · | |
| Enterprise Value | · | · | · | $119M | $669M | $688M | $108M | · | |
| P/E | -2.6 | -5.7 | -28.2 | 48.5 | -4.8 | · | · | · | |
| P/S | 2.1 | 3.0 | 5.1 | 2.2 | 79.0 | 119.1 | 7.9 | · | |
| P/B | 0.8 | 1.9 | 3.0 | 1.7 | 4.3 | 2.9 | 6.4 | · | |
| P / Tangible Book | 0.8 | 1.9 | 3.0 | 1.7 | 4.3 | 2.9 | · | · | |
| P / Cash Flow | -2.3 | -7.7 | -46.7 | 14.1 | -7.2 | -26.5 | -25.5 | · | |
| P / FCF | -2.3 | -7.6 | -40.3 | 18.6 | -7.0 | -25.5 | -22.7 | · | |
| EV / EBITDA | · | · | · | 9.8 | -3.3 | -9.6 | -4.2 | · | |
| EV / FCF | · | · | · | 4.9 | -4.8 | -15.4 | -14.9 | · | |
| EV / Revenue | · | · | · | 0.6 | 54.1 | 72.2 | 5.2 | · | |
| Earnings Yield | -39.1% | -17.7% | -3.5% | 2.1% | -20.9% | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3M | $2M | $7M | $17M | $28M | $29M | $23M | $42M | $50M | $38M | $31M | $45M | $11M | $80M | $160M | $13M | |
| R&D Expense | $18M | $22M | $24M | $23M | $30M | $35M | $44M | $39M | $59M | $54M | $37M | $51M | $53M | $52M | $27M | $38M | |
| SG&A Expense | $11M | $9M | $14M | $10M | $10M | $11M | $12M | $13M | $12M | $15M | $13M | $13M | $13M | $14M | $12M | $12M | |
| Operating Expenses | $29M | $31M | $39M | $34M | $40M | $46M | $56M | $52M | $71M | $68M | $49M | $64M | $66M | $66M | $39M | $50M | |
| Operating Income | $-26M | $-29M | $-31M | $-17M | $-12M | $-17M | $-33M | $-11M | $-21M | $-30M | $-18M | $-19M | $-55M | $15M | $121M | $-37M | |
| Other Non-op | $-59.0K | $35.0K | $2M | $3M | $-127.0K | $-21.0K | $3M | $4M | $4M | $4M | $7M | $4M | $3M | $2M | $1M | $-321.0K | |
| Pretax Income | $-24M | · | $-29M | $-13M | $-9M | $-14M | $-30M | $-7M | $-17M | $-26M | $-11M | $-15M | $-52M | $51M | $119M | $-35M | |
| Income Tax | $0 | · | · | $0 | $4.0K | $0 | $-5.0K | $-217.0K | $-150.0K | $368.0K | $262.0K | $893.0K | $577.0K | $103.0K | $1M | $0 | |
| Net Income | $-24M | $-27M | $-29M | $-13M | $-9M | $-14M | $-30M | $-7M | $-17M | $-27M | $-12M | $-16M | $-53M | $51M | $117M | $-35M | |
| EPS (Basic) | $-0.84 | $-0.95 | $-1.05 | $-0.49 | $-0.34 | $-0.52 | $-1.10 | $-0.26 | $-0.64 | $-1.00 | $-0.44 | $-0.61 | $-1.98 | $1.91 | $4.44 | $-1.33 | |
| EPS (Diluted) | $-0.84 | $-0.95 | $-1.05 | $-0.49 | $-0.34 | $-0.52 | $-1.10 | $-0.26 | $-0.64 | $-1.00 | $-0.40 | $-0.61 | $-1.98 | $1.87 | $4.44 | $-1.33 | |
| Shares (Basic) | 28,423,000 | 28,421,000 | · | 27,188,000 | 27,129,000 | 27,107,000 | · | 27,062,000 | 26,967,000 | 26,879,000 | · | 26,574,000 | 26,563,000 | 26,555,000 | · | 26,467 | |
| Shares (Diluted) | 28,423,000 | 28,421,000 | · | 27,188,000 | 27,129,000 | 27,107,000 | · | 27,062,000 | 26,967,000 | 26,879,000 | · | 26,574,000 | 26,563,000 | 27,149,000 | · | 26,467 | |
| EBITDA | $-26M | $-29M | · | $-17M | $-12M | $-17M | · | $-11M | $-21M | $-30M | · | $-19M | $-55M | $15M | · | $-37M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $191M | $211M | $231M | $180M | $196M | $217M | $237M | $237M | $260M | $288M | $292M | $312M | $323M | $328M | $392M | $238M | |
| Receivables | $2M | $1M | $6M | $8M | $17M | $15M | $4M | $30M | $24M | $27M | · | $38M | $3M | $92M | · | $2M | |
| Current Assets | $197M | $217M | $241M | $249M | $275M | $279M | $306M | $331M | $347M | $376M | · | $393M | $385M | $425M | · | $247M | |
| PP&E (Net) | $5M | $6M | $7M | $7M | $8M | $9M | $10M | $10M | $11M | $12M | · | $13M | $13M | $13M | · | $11M | |
| PP&E (Gross) | $18M | $19M | $19M | $19M | $21M | $21M | $21M | $21M | $21M | $21M | · | $21M | $20M | $19M | · | $17M | |
| Accum. Depreciation | $13M | $13M | $12M | $12M | $13M | $13M | $12M | $11M | $10M | $9M | · | $8M | $7M | $6M | · | $5M | |
| Total Assets | $224M | $245M | $271M | $282M | $309M | $332M | $344M | $371M | $389M | $419M | · | $458M | $431M | $471M | · | $294M | |
| Accounts Payable | $4M | $4M | $4M | $5M | $11M | $6M | $7M | $10M | $14M | $9M | · | $18M | $14M | $19M | · | $18M | |
| Accrued Liabilities | $23M | $23M | $24M | $19M | $25M | $31M | $39M | $32M | $35M | $35M | · | $29M | $29M | $32M | · | $26M | |
| Current Liabilities | $34M | $34M | $36M | $32M | $47M | $49M | $65M | $69M | $92M | $115M | · | $88M | $90M | $90M | · | $76M | |
| Capital Leases | $19M | $20M | $21M | $22M | $23M | $24M | $25M | $26M | $27M | $28M | · | $27M | $28M | $29M | · | $31M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $976.0K | $1M | $2M | · | $4M | |
| Total Liabilities | $53M | $54M | $57M | $58M | $78M | $98M | $103M | $109M | $130M | $155M | · | $178M | $145M | $142M | · | $148M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $13M | |
| Total Debt | · | · | · | · | · | $15M | · | · | · | · | · | $20M | · | · | · | $60M | |
| Common Stock | $28.0K | $28.0K | $28.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | · | $27.0K | $27.0K | $27.0K | · | $26.0K | |
| Paid-in Capital | $737M | $733M | $729M | $710M | $703M | $697M | $690M | $681M | $670M | $659M | · | $636M | $625M | $617M | · | $601M | |
| Retained Earnings | $-565M | $-542M | $-515M | $-486M | $-472M | $-463M | $-449M | $-419M | $-412M | $-395M | · | $-356M | $-340M | $-287M | · | $-455M | |
| Stockholders' Equity | $172M | $191M | $214M | $225M | $231M | $234M | $241M | $262M | $259M | $264M | $279M | $280M | $285M | $329M | $270M | $146M | |
| Liabilities + Equity | $224M | $245M | $271M | $282M | $309M | $332M | $344M | $371M | $389M | $419M | · | $458M | $431M | $471M | · | $294M | |
| Shares Outstanding | 28,423,000 | 28,423,000 | 28,414,000 | 27,235,000 | 27,148,000 | · | 27,000,000 | 27,084,000 | 27,042,000 | 26,917,000 | · | 26,723,000 | 26,574,000 | 26,555,000 | · | 26,492,000 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $600.0K | $658.0K | $624.0K | $800.0K | $800.0K | $801.0K | $840.0K | $900.0K | $900.0K | $904.0K | $879.0K | $800.0K | $700.0K | $578.0K | $503.0K | $400.0K | |
| Stock-based Comp | $4M | $4M | $7M | $6M | $6M | $7M | $9M | $9M | $9M | $10M | $9M | $9M | $8M | $8M | $7M | $9M | |
| Operating Cash Flow | $-20M | $-19M | $-16M | $-17M | $-6M | $-35M | $-284.0K | $-24M | $-30M | $-6M | $-629.0K | $-32M | $51M | $-36M | $160M | $-42M | |
| CapEx | $0 | $0 | $-88.0K | $181.0K | $0 | $137.0K | $0 | $80.0K | $328.0K | $240.0K | $875.0K | $981.0K | $354.0K | $691.0K | $4M | $2M | |
| Investing Cash Flow | $18.0K | $34.0K | $88.0K | $-181.0K | $0 | $-137.0K | $0 | $-80.0K | $-328.0K | $-240.0K | $-875.0K | $-981.0K | $-354.0K | $-691.0K | $-4M | $-2M | |
| Financing Cash Flow | $0 | $16.0K | $12M | $1M | $-15M | $15M | $134.0K | $693.0K | $2M | $2M | $-19M | $22M | $94.0K | $-27M | $-2M | $-1M | |
| Net Change in Cash | $-20M | $-19M | $-4M | $-16M | $-20M | $-20M | $-150.0K | $-23M | $-28M | $-4M | $-20M | $-12M | $51M | $-64M | $154M | $-46M | |
| Free Cash Flow | · | $-19M | · | · | · | $-35M | · | · | · | $-6M | · | · | · | $-37M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -863.3% | -1403.7% | · | -96.3% | -41.0% | -57.3% | · | -25.8% | -42.4% | -80.0% | · | -42.8% | -526.4% | 18.4% | · | -275.3% | |
| Net Margin | -803.8% | -1308.3% | · | -78.4% | -32.4% | -47.9% | · | -16.6% | -34.5% | -70.5% | · | -35.9% | -499.6% | 63.2% | · | -263.8% | |
| Pretax Margin | -803.8% | · | · | -78.4% | -32.4% | -47.9% | · | -17.1% | -34.8% | -69.6% | · | -34.0% | -494.1% | 63.3% | · | · | |
| EBITDA Margin | -863.3% | -1403.7% | · | -96.3% | -41.0% | -57.3% | · | -25.8% | -42.4% | -80.0% | · | -42.8% | -526.4% | 18.4% | · | -275.3% | |
| ROA | -8.9% | -9.3% | · | -4.1% | -2.6% | -3.8% | · | -1.7% | -4.2% | -6.0% | · | -4.3% | -13.7% | 12.5% | · | -9.7% | |
| ROE | -11.8% | -12.7% | · | -5.5% | -3.8% | -5.7% | · | -2.5% | -6.3% | -9.0% | · | -7.6% | -23.1% | 19.8% | · | -17.4% | |
| ROIC | -14.9% | · | · | · | -5.0% | -6.8% | · | -4.0% | -8.1% | -11.7% | · | -6.8% | -19.6% | 4.5% | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.9 | 6.3 | · | 7.9 | 5.9 | 5.6 | · | 4.8 | 3.8 | 3.3 | · | 4.5 | 4.3 | 4.7 | · | 3.3 | |
| Quick Ratio | 5.8 | 6.2 | · | 5.9 | 4.6 | 4.7 | · | 3.8 | 3.1 | 2.7 | · | 4.0 | 3.6 | 4.7 | · | 3.2 | |
| Debt / Equity | · | · | · | · | · | 0.1 | · | · | · | · | · | 0.1 | · | · | · | 0.4 | |
| LT Debt / Equity | · | · | · | · | · | 0.1 | · | · | · | · | · | 0.1 | · | · | · | 0.2 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.2 | · | 0.0 | |
| Receivables Turnover | 0.3 | 0.3 | · | 0.9 | 1.4 | 1.4 | · | 1.2 | 3.7 | 0.6 | · | 2.2 | 4.2 | 1.7 | · | 6.6 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.04 | $6.73 | · | $8.25 | $8.51 | · | · | $9.67 | $9.56 | $9.81 | · | $10.48 | $10.73 | $12.40 | · | $5.50 | |
| Revenue / Share | $0.10 | $0.07 | · | $0.63 | $1.04 | $1.08 | · | $1.54 | $1.85 | $1.41 | · | $1698.65 | $396.00 | $2957.20 | · | $0.51 | |
| Cash Flow / Share | · | $-0.68 | · | · | · | $-1.30 | · | · | · | $-0.21 | · | · | · | $-1321.26 | · | · | |
| Cash / Share | $6.74 | $7.44 | · | $6.62 | $7.24 | · | · | $8.76 | $9.63 | $10.71 | · | $11.67 | $12.17 | $12.35 | · | $8.97 | |
| EPS (TTM) | $-3.33 | $-2.83 | · | $-2.45 | $-2.22 | $-2.52 | · | $-2.30 | $-2.65 | $-3.99 | · | $3.72 | $3.00 | $4.16 | · | $-5.56 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $29M | $55M | · | $98M | $122M | $144M | · | $160M | $164M | $125M | · | $296M | $264M | $281M | · | $52M | |
| Net Income TTM | $-93M | $-79M | · | $-67M | $-60M | $-68M | · | $-63M | $-72M | $-107M | · | $99M | $80M | $111M | · | $-147M | |
| Market Cap | $191M | $219M | · | $502M | $353M | · | · | $629M | $658M | $909M | · | $683M | $762M | $637M | · | $393M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $391M | · | · | · | $215M | |
| P/E | -2.0 | -2.7 | · | -7.5 | -5.9 | -4.2 | · | -10.1 | -9.2 | -8.5 | · | 6.9 | 9.6 | 5.8 | · | -2.7 | |
| P/S | 6.5 | 4.0 | · | 5.1 | 2.9 | · | · | 3.9 | 4.0 | 7.3 | · | 2.3 | 2.9 | 2.3 | · | 7.6 | |
| P/B | 1.1 | 1.1 | · | 2.2 | 1.5 | · | · | 2.4 | 2.5 | 3.4 | · | 2.4 | 2.7 | 1.9 | · | 2.7 | |
| P / Tangible Book | 1.1 | 1.1 | · | 2.2 | 1.5 | · | · | 2.4 | 2.5 | 3.4 | · | 2.4 | 2.7 | 1.9 | · | 2.7 | |
| P / Cash Flow | · | -11.3 | · | · | · | · | · | · | · | -163.6 | · | · | · | -17.7 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | 1.3 | · | · | · | 4.2 | |
| Earnings Yield | -49.5% | -36.7% | · | -13.3% | -17.1% | -23.8% | · | -9.9% | -10.9% | -11.8% | · | 14.6% | 10.5% | 17.4% | · | -37.5% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $82M | $152M | $167M | $206M | $12M |
| Betriebsgewinnmarge % | -93.0% | -62.8% | -46.9% | 5.9% | -1641.3% |
| Nettoergebnis | $-66M | $-81M | $-30M | $9M | $-204M |
| Verwässerte EPS | $-2.40 | $-3.00 | $-1.12 | $0.35 | $-7.74 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | · | · | · | 0.2 | 0.3 |
| Liquiditätsgrad | 6.6 | 4.7 | 4.7 | 3.2 | 3.8 |
| Quick Ratio | 6.5 | 3.7 | 4.0 | 3.1 | 3.8 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-75M | $-60M | $-21M | $24M | $-138M |
Institutionelle Eigentümer (13F) 148 Einreicher · $183.0M gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
148
Gehaltener Wert
$183.0M
Neue Positionen
23
Geschlossene Positionen
8
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 23 (-7 vs. Vorquartal) | 8 (-14 vs. Vorquartal) | 55 (+8 vs. Vorquartal) | 40 (+3 vs. Vorquartal) | +365K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FEDERATED HERMES, INC. | $22.200.461 | 3.303.640 | 12,13% | Aktien |
| ARK Investment Management LLC | $19.498.987 | 2.901.635 | 10,65% | Aktien |
| BlackRock, Inc. | $17.566.162 | 2.614.012 | 9,60% | Aktien |
| Sumitomo Mitsui Trust Group, Inc. | $13.192.187 | 1.963.123 | 7,21% | Aktien |
| Amova Asset Management Americas, Inc. | $13.135.069 | 1.960.458 | 7,18% | Aktien |
| VANGUARD GROUP INC | $12.809.499 | 2.089.641 | 7,00% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $7.492.504 | 1.114.956 | 4,09% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $7.332.441 | 1.091.137 | 4,01% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6.394.584 | 951.575 | 3,49% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $4.662.359 | 693.660 | 2,55% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $4.536.095 | 675.014 | 2,48% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $4.351.274 | 647.511 | 2,38% | Aktien |
| STATE STREET CORP | $3.827.699 | 569.598 | 2,09% | Aktien |
| UBS Group AG | $3.297.047 | 490.632 | 1,80% | Aktien |
| TWO SIGMA ADVISERS, LP | $3.132.694 | 511.043 | 1,71% | Aktien |
| D. E. Shaw & Co., Inc. | $2.636.646 | 392.358 | 1,44% | Aktien |
| Empire Life Investments Inc. | $2.460.978 | 366.217 | 1,34% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $2.264.613 | 336.996 | 1,24% | Aktien |
| GOLDMAN SACHS GROUP INC | $2.082.279 | 309.863 | 1,14% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $1.759.222 | 261.789 | 0,96% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.556.540 | 231.628 | 0,85% | Aktien |
| Point72 Asset Management, L.P. | $1.556.231 | 231.582 | 0,85% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $1.487.478 | 221.322 | 0,81% | Aktien |
| HEARTLAND ADVISORS INC | $1.473.696 | 219.300 | 0,81% | Aktien |
| HAP Trading, LLC | $1.421.727 | 77.142 | 0,78% | Aktien |
| NORTHERN TRUST CORP | $1.374.765 | 204.578 | 0,75% | Aktien |
| JPMORGAN CHASE & CO | $1.334.701 | 195.704 | 0,73% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $1.169.603 | 174.048 | 0,64% | Aktien |
| Jump Financial, LLC | $928.765 | 138.209 | 0,51% | Aktien |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | $849.341 | 126.390 | 0,46% | Aktien |
| Invesco Ltd. | $700.144 | 104.188 | 0,38% | Aktien |
| MORGAN STANLEY | $654.568 | 97.406 | 0,36% | Aktien |
| Quantinno Capital Management LP | $577.080 | 85.875 | 0,32% | Aktien |
| Bank of New York Mellon Corp | $539.711 | 80.314 | 0,29% | Aktien |
| Belmont Capital, LLC | $520.400 | 40.000 | 0,28% | Aktien |
| MARSHALL WACE, LLP | $519.247 | 77.269 | 0,28% | Aktien |
| Russell Investments Group, Ltd. | $510.070 | 75.903 | 0,28% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $439.226 | 65.361 | 0,24% | Aktien |
| AMERIPRISE FINANCIAL INC | $438.694 | 65.282 | 0,24% | Aktien |
| HSBC HOLDINGS PLC | $393.713 | 56.895 | 0,22% | Aktien |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $386.266 | 57.480 | 0,21% | Aktien |
| Nuveen, LLC | $353.082 | 52.542 | 0,19% | Aktien |
| Squarepoint Ops LLC | $337.700 | 50.253 | 0,18% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $319.583 | 47.557 | 0,17% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $290.916 | 43.291 | 0,16% | Aktien |
| CITADEL ADVISORS LLC | $275.157 | 40.946 | 0,15% | Aktien |
| WOLVERINE TRADING, LLC | $274.376 | 14.610 | 0,15% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $272.362 | 35.280 | 0,15% | Aktien |
| nVerses Capital, LLC | $261.743 | 38.950 | 0,14% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $245.280 | 36.500 | 0,13% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. ×5 Einreichungen | 26. Oktober 2021 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 17 Insider · 8 Führungskräfte · 11 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Joseph E Payne | President and CEO | 17. Dezember 2025 A | 1.480.097 | 0 | 0 | $0 |
| Dennis Mulroy | Chief Financial Officer | 1. Mai 2026 A | · | 0 | 0 | $0 |
| Andy Sassine | Chief Financial Officer | 15. August 2025 P | 221.764 | 0 | 0 | $0 |
| Pad Chivukula | Chief Scientific Officer & COO | 17. Dezember 2025 A | 435.334 | 0 | 0 | $0 |
| Joseph Roberts | Controller | 17. Dezember 2025 A | · | 0 | 0 | $0 |
| Lance Kurata | Chief Legal Officer | 17. Dezember 2025 A | · | 0 | 0 | $0 |
| Keith C Kummerfeld | Senior Vice President of Finance (Principal Accounting Officer) | 15. Dezember 2023 A | 950 | 0 | 0 | $0 |
| Steven George Hughes | Chief Development Officer | 18. Dezember 2020 A | · | 0 | 0 | $0 |
| Jing L. Marantz | Direktor | 5. Juni 2026 A | 3.131 | 0 | 0 | $0 |
| John Markels | Direktor | 5. Juni 2026 A | 3.131 | 0 | 0 | $0 |
| Moncef Slaoui | Direktor | 5. Juni 2026 A | · | 0 | 0 | $0 |
| Magda Marquet | Direktor | 5. Juni 2026 A | 3.131 | 0 | 0 | $0 |
| Edward W Holmes | Direktor | 5. Juni 2026 A | 3.131 | 0 | 0 | $0 |
| James F Barlow | Direktor | 5. Juni 2026 A | 13.131 | 0 | 0 | $0 |
| FARRELL PETER C | Direktor | 5. Juni 2026 A | 55.741 | 0 | 0 | $0 |
| Ultragenyx Pharmaceutical Inc. | Direktor | 11. August 2021 S | 1.400.000 | 0 | 0 | $0 |
| Karah Herdman Parschauer | Direktor | 18. Juni 2021 A | · | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 19 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| ARKG · ARK ETF Trust | 1,01% | 2.741.123 NS | 31. Juli 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,34% | 103.526 SH | 2. Oktober 2026 | Täglich |
| IWC · iShares Trust | 0,09% | 91.378 SH | 11. September 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,05% | 90.471 SH | 2. Oktober 2026 | Täglich |
| IBB · iShares Trust | 0,03% | 202.701 SH | 11. September 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,03% | 2.039 SH | 2. Oktober 2026 | Täglich |
| IWM · iShares Trust | 0,01% | 699.366 SH | 11. September 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 153.611 SH | 19. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 23.343 SH | 19. August 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 12.811 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 9.028 SH | 11. September 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,00% | 14.428 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 24.073 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 3.714 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 293.104 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 797.154 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.156 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,00% | 71.680 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 252.542 SH | 11. September 2026 | Täglich |
ARCT Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 18 Analysten
KAUF
Median-Ziel
$20.00
+53,5%
5 27,8%
Starker Kauf
9 50,0%
Kauf
4 22,2%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
10 Analysten · 2026-10-03Mittelwert-Ziel $23.20 +78,1%
Jetzt
Aktueller Preis $13.03
Tief$9.00
Mittelwert$23.20
Hoch$41.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ARCT | $174M | -2.6 | -46.1% | -80.2% | -29.6% | · |
| XFOR | $364M | -2.1 | 150.0% | -1218.5% | -83.2% | · |
| RCEL | $105M | -2.0 | 11.5% | -67.8% | 328.9% | 82.1% |
| ENTA | $256M | -3.1 | -3.4% | -125.4% | -103.5% | · |
| FENC | $263M | -22.6 | -6.1% | -21.8% | -69.6% | · |
| CYPH | $97M | 16.6 | · | · | 6.1% | · |
| SRZN | · | · | · | · | · | · |
| ZNTL | $93M | -0.7 | · | · | -49.5% | · |
| OCGN | $422M | -5.6 | 8.8% | -1537.4% | 1488.8% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026